Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

High-Tech Surgical Tools Hold Promise Despite Complexity – Circulation

This article was originally published in The Gray Sheet

Executive Summary

The surgical community's interest in minimally invasive coronary procedures will continue to provide medical device companies with a wealth of opportunities to develop new, innovative products, according to a leading cardiac surgeon

You may also be interested in...



Intuitive Surgical’s New da Vinci Indications To Grow Sales By 40% In 2005

Expanded indications and premium-priced accessories for Intuitive Surgical's da Vinci robotic surgery system will drive a sales growth of at least 40% to $194 mil. by year-end, according to the company

Cardica’s Pooled Anastomosis Device Data Fail To Connect With FDA Panel

Cardica, Inc.'s PAS Port proximal anastomosis device has appeal as a less invasive alternative to suturing for coronary bypass surgery, but the firm lacks sufficient data to demonstrate safety and effectiveness, FDA's Circulatory System Devices Panel members agreed April 22

Neuroscience Challenges Oncology For Top Spot In CDER’s 2019 Novel Approvals

Oncology R&D isn’t waning, but investment in neurology and psychiatry drug development are paying off in new drug approvals. Rapid growth in CDER non-malignant hematology approvals reflects longer, broader trend toward orphan drugs.

UsernamePublicRestriction

Register

MT023898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel